Does ALEMTUZUMAB Cause Eosinophil count increased? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Eosinophil count increased have been filed in association with ALEMTUZUMAB (Campath). This represents 0.8% of all adverse event reports for ALEMTUZUMAB.
108
Reports of Eosinophil count increased with ALEMTUZUMAB
0.8%
of all ALEMTUZUMAB reports
0
Deaths
33
Hospitalizations
How Dangerous Is Eosinophil count increased From ALEMTUZUMAB?
Of the 108 reports, 33 (30.6%) required hospitalization, and 2 (1.9%) were considered life-threatening.
Is Eosinophil count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Eosinophil count increased?
ALBUTEROL (1,359)
PREDNISONE (846)
BUDESONIDE\FORMOTEROL (719)
DUPILUMAB (712)
TIOTROPIUM (682)
MEPOLIZUMAB (670)
MONTELUKAST (504)
BUDESONIDE (493)
CLOZAPINE (475)
FLUTICASONE\SALMETEROL (416)
Which ALEMTUZUMAB Alternatives Have Lower Eosinophil count increased Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET